A remitted patient with ARFID faces panic after a crash, showing why recovery includes somatic fear, not just eating behavior.
|Videos|December 14, 2021
Resiliency in BPD Treatment
Author(s)Karen L. Jacob, PhD
Why is resiliency important for patients with borderline personality disorder—and the clinicians who treat them?
Advertisement
About 14 million Americans will be diagnosed with borderline personality disorder (BPD) at some point in their lives. In this Mental Health Minute video, Karen L. Jacob, PhD, program director of the Gunderson Residence and assistant professor of psychology in the Harvard Medical School Department of Psychiatry, discusses BPD and how clinicians can integrate resiliency into the treatment process for patients with BPD.
Dr Jacob is program director of the
Advertisement
Related to this article
Lisa Harding, MD, urges psychiatrists to gather histories, deprescribe safely, and send focused sleep referrals now that orexin agonists have arrived for narcolepsy.
Once-monthly subcutaneous olanzapine TEV-749 shows sustained stabilization and remission in schizophrenia, supports direct switching, and avoids post-injection monitoring.
Real-world data links once-monthly Uzedy to fewer ER visits, better adherence, and lower costs—plus fewer bipolar I relapses when switching from pills.
Explore PTSD prevalence, comorbidities, and first-line care as we invite clinicians to share cases and research.
Veterans younger than 30 starting antidepressants, and anyone coprescribed opioids and benzodiazepines, will need to sign consent forms starting in 2027.
How genes and early stress interact to shape antisocial behavior, from dopamine and serotonin pathways to MAOA and oxytocin findings.
Policy shifts have opened the door to telehealth buprenorphine for pregnant and postpartum women with OUD, but research, guidelines, and state policy lag behind.
Advertisement
Advertisement